Consolidated Medical Bio-Analysis INC

Consolidated Medical Bio-Analysis INC was paid $8.87M by Medicaid between Jan 2018 and Dec 2024, across 197 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 26% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in California

Rank by total paid#78 of 561

Median peer was paid$222K

This provider vs. median40×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	379,554	$1.33M
2019	351,813	$1.18M
2020	303,898	$1.66M
2021	344,033	$2.07M
2022	293,015	$1.33M
2023	314,486	$719K
2024incomplete	311,075	$580K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	26%	33,811	17,168	$2.31M
88305	Level IV - Surgical pathology, gross and microscopic examination	7.7%	11,275	11,133	$687K
88142		7.7%	39,178	38,840	$679K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	7.1%	18,539	18,444	$633K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	3.9%	37,219	36,455	$350K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	3.8%	36,286	35,547	$334K
87517		3.2%	8,146	8,084	$287K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	2.6%	216,558	203,223	$228K
80061	Lipid panel	2.5%	184,335	183,307	$220K
84443	Thyroid stimulating hormone (TSH)	2.4%	119,509	118,123	$215K
80053	Comprehensive metabolic panel	2.4%	210,413	204,481	$214K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	2.2%	4,755	4,437	$193K

185 more codes

83013		2.1%	3,539	$190K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	1.9%	68,978	$167K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	1.9%	15,547	$167K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	1.5%	16,878	$135K
83036	Hemoglobin; glycosylated (A1C)	1.5%	125,360	$134K
88312		1.3%	2,843	$114K
36415	Collection of venous blood by venipuncture	1.3%	172,049	$114K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	1.1%	4,342	$95K
87522	Neg quan hep c or qual rna	1.0%	2,592	$89K
80055		<1%	4,787	$83K
86703		<1%	9,349	$60K
80164		<1%	5,274	$55K
86592		<1%	25,558	$53K
87625		<1%	1,443	$50K
88141		<1%	5,127	$50K
81001		<1%	135,805	$40K
87086	Culture, bacterial; quantitative colony count, urine	<1%	30,878	$40K
80048	Basic metabolic panel (calcium, ionized)	<1%	18,302	$36K
84439		<1%	41,078	$35K
86803		<1%	26,905	$34K
86003		<1%	3,511	$31K
84153		<1%	21,965	$31K
87340		<1%	30,161	$27K
86480		<1%	6,159	$25K
86706		<1%	25,803	$25K
84702		<1%	5,504	$25K
86708		<1%	19,814	$24K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	538	$24K
86704		<1%	20,460	$24K
86769		<1%	730	$22K
80076		<1%	13,206	$22K
82105		<1%	11,013	$19K
84436		<1%	15,077	$16K
82043		<1%	34,727	$15K
83970		<1%	2,472	$13K
82570		<1%	21,476	$13K
87081		<1%	3,948	$12K
82140		<1%	1,237	$12K
84550		<1%	37,109	$12K
80178		<1%	2,367	$12K
82746		<1%	10,583	$12K
88304		<1%	362	$11K
87070		<1%	6,061	$11K
82951		<1%	2,353	$11K
87088		<1%	10,661	$11K
84480		<1%	8,782	$10K
80074		<1%	598	$10K
83880		<1%	902	$9K
86762		<1%	4,605	$9K
82728		<1%	11,344	$8K
84403		<1%	3,040	$8K
87184		<1%	11,206	$8K
82378		<1%	4,387	$7K
P9604	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge	<1%	5,591	$7K
83540		<1%	13,384	$7K
83550		<1%	10,448	$7K
84479		<1%	7,545	$7K
82785		<1%	3,103	$6K
82977		<1%	12,410	$6K
86696		<1%	2,361	$6K
80159		<1%	410	$6K
86780		<1%	979	$6K
86141		<1%	2,802	$6K
84481		<1%	4,756	$6K
82550		<1%	7,607	$5K
85610		<1%	8,937	$5K
83655		<1%	3,337	$5K
82950		<1%	3,131	$5K
83735		<1%	4,319	$5K
82607		<1%	11,645	$5K
84100		<1%	11,993	$5K
83001		<1%	3,388	$5K
87076		<1%	1,205	$5K
86235		<1%	5,236	$4K
86038		<1%	5,319	$4K
83002		<1%	2,569	$4K
83615		<1%	12,134	$4K
86695		<1%	2,123	$4K
82947		<1%	6,131	$4K
82670		<1%	1,687	$4K
86304		<1%	2,047	$4K
86300		<1%	1,858	$4K
82270		<1%	13,697	$4K
84146		<1%	2,844	$4K
85730		<1%	5,015	$4K
82274		<1%	3,563	$4K
83020		<1%	1,057	$3K
84402		<1%	1,236	$3K
86694		<1%	1,633	$3K
86039		<1%	2,844	$3K
86735		<1%	3,860	$3K
86765		<1%	4,127	$3K
86787		<1%	3,948	$3K
87902		<1%	13	$3K
86431		<1%	5,636	$3K
85651		<1%	13,287	$3K
81025		<1%	1,371	$3K
87186		<1%	516	$2K
86140		<1%	7,474	$2K
83690		<1%	3,197	$2K
82150		<1%	2,957	$2K
87210		<1%	756	$2K
87341		<1%	2,424	$2K
86677		<1%	1,281	$2K
86900		<1%	2,447	$2K
86901		<1%	2,445	$2K
84144		<1%	845	$1K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	24	$1K
87510		<1%	1,105	$1K
87480		<1%	1,105	$1K
87660		<1%	1,105	$1K
82465		<1%	5,386	$1K
88112		<1%	196	$1K
85027		<1%	1,832	$1K
84156		<1%	3,193	$1K
87350		<1%	3,209	$1K
86376		<1%	1,698	$1K
84478		<1%	4,760	$1K
87536		<1%	14	$953.12
86301		<1%	932	$837.98
83014		<1%	1,923	$789.57
86225		<1%	1,507	$772.82
87177		<1%	727	$695.58
86850		<1%	430	$599.45
82784		<1%	1,563	$574.48
84681		<1%	473	$567.92
82565		<1%	1,402	$562.19
86709		<1%	1,988	$532.95
84460		<1%	3,347	$528.73
82627		<1%	338	$496.28
86800		<1%	789	$488.76
86200		<1%	1,684	$477.22
86707		<1%	3,059	$472.71
85045		<1%	1,325	$451.52
87338		<1%	1,711	$444.14
85018		<1%	444	$408.65
84703		<1%	2,125	$405.96
85014		<1%	427	$388.70
83525		<1%	1,123	$369.40
84450		<1%	2,552	$364.72
80069		<1%	1,036	$347.83
84134		<1%	46	$344.19
82248		<1%	1,076	$310.71
86160		<1%	495	$307.38
86381		<1%	125	$292.20
84520		<1%	785	$271.06
87045		<1%	166	$258.71
83516		<1%	1,087	$245.96
86161		<1%	354	$207.49
86015		<1%	94	$162.07
86162		<1%	102	$144.00
82533		<1%	134	$140.25
87529		<1%	42	$128.56
83721		<1%	424	$107.98
84132		<1%	164	$91.17
86328		<1%	28	$90.46
84154		<1%	50	$77.87
86705		<1%	76	$65.10
88173		<1%	25	$61.55
81374		<1%	12	$55.00
80177		<1%	12	$41.12
82247		<1%	151	$39.01
84165		<1%	161	$39.00
83010		<1%	217	$33.26
82435		<1%	15	$28.21
82310		<1%	44	$25.05
84295		<1%	15	$24.30
83883		<1%	157	$23.83
86317		<1%	273	$23.25
82952		<1%	14	$22.79
84155		<1%	194	$20.88
82330		<1%	424	$20.25
83090		<1%	311	$15.03
83520		<1%	43	$14.34
82172		<1%	95	$13.75
82103		<1%	12	$7.16
86063		<1%	12	$4.63
83935		<1%	35	$4.21
87205		<1%	26	$3.62
82107		0%	22	$0.00
85379		0%	12	$0.00
G0123	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision	0%	14	$0.00
85652		0%	12	$0.00
83021		0%	26	$0.00
86364		0%	13	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialFAN, CHIN (PRESIDENT)